Pulike Biological Engineering, Inc. (SHA:603566)
China · Delayed Price · Currency is CNY 9.38
+0.07 (0.75%)
Nov 5, 2026, 3:00 PM CST
SHA:603566 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,005 | 1,090 | 1,043 | 1,253 | 1,230 | 1,099 |
Revenue Growth | -8.96% | 4.54% | -16.77% | 1.84% | 11.97% | 18.32% |
Gross Profit Gross Profit Growth | 564.84 | 652.53 | 636.93 | 764.3 | 770.33 | 718.62 |
Operating Income Operating Income Growth | 91.23 | 178.73 | 107.19 | 170.89 | 175.86 | 222.11 |
Net Income Net Income Growth | 107.4 | 184.99 | 92.81 | 174.52 | 167.82 | 244.14 |
Earnings Per Share EPS Growth | 0.31 | 0.54 | 0.27 | 0.50 | 0.52 | 0.78 |
EPS Growth | -25.88% | 100.00% | -46.00% | -3.85% | -33.33% | 8.33% |
Fiscal Year | TTM | FY 2025 |
|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 |
Pig Vaccine Pig Vaccine Growth | 210.62 | 263.11 |
Poultry Vaccines and Antibodies Poultry Vaccines and Antibodies Growth | 457.99 | 485.23 |
Vaccines for Ruminants Vaccines for Ruminants Growth | 17.97 | 6.38 |
Pets Pets Growth | 14.52 | 16.09 |
Chemical Chemical Growth | 243.5 | 253.71 |
Functional Health Products, Etc. Functional Health Products, Etc. Growth | 19.1 | 24.65 |
Technology Licensing or Transfer Income Technology Licensing or Transfer Income Growth | 25.94 | 27.78 |
Total Total Growth | 989.62 | 1,077 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 800.75 | 773.16 | 685.59 | 724.79 | 973.01 | 243.83 |
Total Debt Total Debt Growth | 25.52 | 27.23 | 1.26 | 2.05 | 9.69 | - |
Net Cash (Debt) Net Cash Growth | 775.23 | 745.92 | 684.33 | 722.74 | 963.32 | 243.83 |
Net Cash Growth | -2.33% | 9.00% | -5.31% | -24.97% | 295.08% | -53.03% |
Net Cash Per Share Net Cash Per Share Growth | 2.24 | 2.18 | 1.99 | 2.07 | 2.98 | 0.78 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 225.86 | 356.34 | 268.79 | 282.78 | 228.36 | 212.53 |
Capital Expenditures CapEx Growth | -60.79 | -75.04 | -121.06 | -304.98 | -357.16 | -317.54 |
Free Cash Flow Free Cash Flow Growth | 165.06 | 281.3 | 147.73 | -22.2 | -128.8 | -105.01 |
Free Cash Flow Growth | -51.13% | 90.42% | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 56.21% | 59.87% | 61.09% | 61.01% | 62.63% | 65.41% |
Operating Margin | 9.08% | 16.40% | 10.28% | 13.64% | 14.30% | 20.22% |
Pretax Margin | 9.52% | 19.02% | 9.47% | 15.54% | 14.45% | 25.87% |
Profit Margin | 10.69% | 16.97% | 8.90% | 13.93% | 13.64% | 22.22% |
FCF Margin | 16.43% | 25.81% | 14.17% | -1.77% | -10.47% | -9.56% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.600 | 0.600 | 0.400 | 0.700 | 0.350 | 0.200 |
Dividend Per Share Growth | 50.00% | 50.00% | -42.86% | 100.00% | 75.00% | -60.00% |
Dividend Yield | 6.40% | 4.83% | 3.14% | 3.09% | 1.28% | 0.91% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 30.20 | 22.97 | 47.01 | 44.91 | 56.42 | 28.48 |
Forward PE | 22.33 | 20.38 | 19.73 | 27.90 | 35.98 | 21.72 |
P/FCF Ratio | 19.43 | 15.11 | 29.53 | - | - | - |
PS Ratio | 3.19 | 3.90 | 4.18 | 6.26 | 7.70 | 6.33 |